IBB: Beyond The 2025 Surge, Biotech Breakout
Source: SeekingAlpha
2026-01-27 05:10:39 ET
After a multi-year drought, the iShares Biotechnology ETF ( IBB ) has been quietly having a fantastic run, returning about 28% for 2025, dwarfing its modest returns in 2023, alongside losses in 2022, 2024, amid a renewed risk appetite, a healthy environment of IPO & M&A activity, alongside a sturdy show by large-cap biotechs, where IBB derives its weights from....
Read the full article on Seeking Alpha
For further details see:
IBB: Beyond The 2025 Surge, Biotech Breakout
Novartis AG
NASDAQ: NVS
NVS Trading
-0.32% G/L:
$154.04 Last:
978,559 Volume:
$154.69 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
February 22, 2026 03:07:00 pm
Novartis: This Big Pharma Giant Could Be a Sleep?at?Night Core Holding for Decades
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
